Ascendis Pharma A/S (ASND) Ownership
ASND ownership summary
as of October 18, 2026- Institutions
- 103.0% of shares outstanding
- Insiders
- 0.77% of shares outstanding
- Shares outstanding
- 65.8M
- Float
- 65.6M shares available to trade
- Short interest
- 6.27% 3.5M shares short
- Days to cover
- 3.87 short interest down 12.1% vs prior month
- Institutions 103.00%
- Insiders 0.77%
ASND top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 0.34% | 225K | $50.7M | +91,822 (+68.9%) | June 30, 2026 |
| 2 | Neuberger Berman Group LLC | 0.22% | 143K | $32.1M | +142,705 (0.0%) | June 30, 2026 |
| 3 | ODDO BHF Asset Management SAS | 0.20% | 129K | $29.0M | — | June 30, 2026 |
| 4 | Quadrature Capital Limited | 0.06% | 41K | $9.2M | +40,845 (0.0%) | June 30, 2026 |
| 5 | Skopos Labs Inc | 0.01% | 4,072 | $917,218 | +1,855 (+83.7%) | March 31, 2026 |
| 6 | Ferguson Wellman Capital Management, Inc | <0.01% | 2,600 | $585,650 | — | June 30, 2026 |
| 7 | Dearborn Partners LLC | <0.01% | 2,600 | $585,650 | +1,300 (+100.0%) | June 30, 2026 |
| 8 | CWM, LLC duplicate | <0.01% | 1,347 | $303,412 | −48 (−3.4%) | March 31, 2026 |
| 9 | E Fund Management (HK) Co., Ltd | <0.01% | 84 | $18,921 | +24 (+40.0%) | June 30, 2026 |
| 10 | Ninepoint Partners LP | 0.00% | 26 | $5,856 | −5,400 (−99.5%) | June 30, 2026 |
| 11 | IFP Advisors, LLC | 0.00% | 14 | $3,154 | +2 (+16.7%) | June 30, 2026 |
| 12 | Huntington National Bank | 0.00% | 1 | $225 | — | June 30, 2026 |
| 13 | Affinity Asset Advisors, LLC | 0.00% | — | — | −95,000 (−100.0%) | June 30, 2026 |
| 14 | AllianceBernstein L.P. | 0.00% | — | — | −278,203 (−100.0%) | June 30, 2026 |
| 15 | Acadian Asset Management LLC | 0.00% | — | — | −34,910 (−100.0%) | March 31, 2026 |
| 16 | Allianz Asset Management AG | 0.00% | — | — | −5,300 (−100.0%) | June 30, 2026 |
| 17 | AlphaCentric Advisors, LLC | 0.00% | — | — | −4,526 (−100.0%) | June 30, 2026 |
| 18 | Ancora Advisors LLC | 0.00% | — | — | −12 (−100.0%) | June 30, 2026 |
| 19 | Amvescap Plc. | 0.00% | — | — | −362,109 (−100.0%) | June 30, 2026 |
| 20 | Atika Capital Management LLC | 0.00% | — | — | −19,125 (−100.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 7 holders added 279K shares and 10 cut 805K.
ASND top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Janus Henderson Hrzn Biotec E2 USD | 0.35% | 228K | $51.5M | — | March 31, 2026 |
| 2 | Xtrackers MSCI World Swap ETF 1C | 0.29% | 188K | $42.3M | +131,518 (+233.8%) | December 31, 2025 |
| 3 | Candriam Eqs L Biotech C USD Cap | 0.28% | 182K | $40.9M | +7,646 (+4.4%) | March 31, 2026 |
| 4 | Spyglass US Growth F USD Inc | 0.11% | 69K | $15.6M | −640 (−0.9%) | March 31, 2026 |
| 5 | TD Health Sciences - I | 0.09% | 59K | $13.2M | −5,101 (−8.0%) | December 31, 2025 |
| 6 | Xtrackers S&P 500 Swap ETF 1C | 0.09% | 58K | $13.2M | −431 (−0.7%) | December 31, 2025 |
| 7 | TD US Mid-Cap Growth - I | 0.09% | 58K | $13.2M | −18,500 (−24.1%) | December 31, 2025 |
| 8 | Candriam Eqs L Life Care V USD Acc | 0.07% | 49K | $11.0M | — | March 31, 2026 |
| 9 | Belfius Equities Glob Health Care C$ Cap | 0.05% | 35K | $7.9M | −86 (−0.2%) | March 31, 2026 |
| 10 | Invesco NASDAQ Next Gen 100 ETF | 0.05% | 30K | $6.7M | +142 (+0.5%) | April 20, 2026 |
| 11 | AMOne Medical Science Fund | 0.03% | 20K | $4.4M | −5,715 (−22.6%) | January 23, 2026 |
| 12 | Russell Inv Tax-Managed US Mid&Sm Cap S | 0.02% | 16K | $3.5M | — | August 31, 2026 |
| 13 | First Trust Long/Short Equity ETF | 0.02% | 15K | $3.5M | — | April 20, 2026 |
| 14 | Rhenman Healthcare Equity L/S RC2 SEK | 0.02% | 15K | $3.4M | — | January 31, 2026 |
| 15 | American Century US Fcs Innovt Eq S USD | 0.02% | 14K | $3.2M | +6 (+0.0%) | March 31, 2026 |
| 16 | First Trust Innovation Leaders ETF | 0.02% | 14K | $3.1M | — | April 20, 2026 |
| 17 | Nomura VIP Global Growth Service | 0.02% | 12K | $2.7M | −152 (−1.3%) | March 31, 2026 |
| 18 | United Global Healthcare SGD Acc | 0.01% | 8,911 | $2.0M | −253 (−2.8%) | March 31, 2026 |
| 19 | Hussman Strategic Market Cycle Fund | 0.01% | 8,000 | $1.8M | +8,000 (0.0%) | March 31, 2026 |
| 20 | Invesco Global Small Cap Equity Pool I | 0.01% | 7,224 | $1.6M | — | March 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ASND shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ASND
Institutional investors own 103.0% of Ascendis Pharma A/S's shares and insiders 0.77%. The largest holder is Frazier Life Sciences Management, L.P. with 0.34% of the shares (225K), as of June 30, 2026. Among the top 20 institutions, 7 added shares and 10 reduced their stake in the latest filings. Short interest is 6.27% of the float, or 3.87 days of average trading volume. The share count rose 151.7% since 2014.
Related: ASND analyst forecast, ASND key metrics. See the ASND stock overview for the latest quote and news.
ASND ownership FAQ
Who owns the most Ascendis Pharma A/S stock?
The largest shareholders of Ascendis Pharma A/S are Frazier Life Sciences Management, L.P. (0.34%), Neuberger Berman Group LLC (0.22%), ODDO BHF Asset Management SAS (0.20%), Quadrature Capital Limited (0.06%), Skopos Labs Inc (0.01%).
What percentage of Ascendis Pharma A/S is owned by institutions?
Institutions hold 103.0% of Ascendis Pharma A/S's shares outstanding; insiders hold 0.77%.
Which funds own Ascendis Pharma A/S?
The largest fund holders of Ascendis Pharma A/S are Janus Henderson Hrzn Biotec E2 USD (0.35%), Xtrackers MSCI World Swap ETF 1C (0.29%), Candriam Eqs L Biotech C USD Cap (0.28%), Spyglass US Growth F USD Inc (0.11%), TD Health Sciences - I (0.09%).
What is Ascendis Pharma A/S's short interest?
3.5M shares of Ascendis Pharma A/S were sold short, 6.27% of the float; at the average daily volume it would take 3.87 days to cover.
How many shares of Ascendis Pharma A/S are outstanding?
Ascendis Pharma A/S has 65.8M shares outstanding, of which 65.6M are in the public float.